Monte Rosa Therapeutics

US · GLUE #3350 by market cap Listed 2021

10.17 +0.30 +3.04%

Live - 5344 symbols - heartbeat 301s ago · 2026-10-08 09:06

Pre-market 10.02 -1.51%

After-hours 10.00 -1.67%

Overnight 10.14 -0.29%

Market cap: 867.64M
P/E (TTM): -5.81
P/B: 1.78
EPS: -0.46
Div yield: 0.00%
52W pos: 7%

Reader sentiment Are you bullish or bearish on GLUE?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

Rating change
Analysts Offer Insights on Healthcare Companies: Monte Rosa Therapeutics (GLUE), Mineralys Therapeutics, Inc. (MLYS) and Adagene (ADAG)
TipRanks · 2026/8/13
Company notice
Lianhuan Pharmaceutical Co., Ltd.: notice of approval of LH-1802 glue for drug clinical trials
SZSI · 2021/11/8
Rating change
J.P. Morgan Maintains Monte Rosa Therapeutics(GLUE.US) With Buy Rating, Cuts Target Price to $27
Market Newswire · 2026/8/11
Rating change
Guggenheim Maintains Monte Rosa Therapeutics(GLUE.US) With Buy Rating, Maintains Target Price $35
Market Newswire · 2026/7/15
Rating change
Wedbush Maintains Monte Rosa Therapeutics(GLUE.US) With Buy Rating, Maintains Target Price $37
Market Newswire · 2026/5/9
Rating change
J.P. Morgan Maintains Monte Rosa Therapeutics(GLUE.US) With Buy Rating, Raises Target Price to $31
Market Newswire · 2026/5/11
Rating change
Jefferies Initiates Monte Rosa Therapeutics(GLUE.US) With Buy Rating, Announces Target Price $25
Market Newswire · 2026/8/1
Guggenheim Maintains Monte Rosa Therapeutics(GLUE.US) With Buy Rating, Maintains Target Price $28
Market Newswire · 2026/10/2
Rating change
Guggenheim Maintains Monte Rosa Therapeutics(GLUE.US) With Buy Rating, Raises Target Price to $35
Market Newswire · 2026/6/30
Analysts Are Bullish on Top Healthcare Stocks: Monte Rosa Therapeutics (GLUE), Sagimet Biosciences, Inc. Class A (SGMT)
TipRanks · 2026/10/5
Company notice
Poly Glue shares: Tianjiankuan (2022) No. 7-494-Verification report on Poly Glue New Materials Co., Ltd. to invest in fund-raising projects and pay issuance fees in advance with self-raised funds
SZSI · 2022/9/6
H.C. Wainwright Maintains Monte Rosa Therapeutics(GLUE.US) With Buy Rating, Maintains Target Price $25
Market Newswire · 2026/10/5
Company notice
Dongyue silicon: the company's 107 glue, silicone oil and other products can be used in the field of solar photovoltaic after deep processing.
SZSI · 2021/9/30
Piper Sandler Maintains Monte Rosa Therapeutics(GLUE.US) With Buy Rating, Maintains Target Price $37
Market Newswire · 2026/10/2
Rating change
Guggenheim Maintains Monte Rosa Therapeutics(GLUE.US) With Buy Rating, Cuts Target Price to $28
Market Newswire · 2026/8/7
H.C. Wainwright Initiates Monte Rosa Therapeutics(GLUE.US) With Buy Rating, Announces Target Price $25
Market Newswire · 2026/10/1
Rating change
Wells Fargo Maintains Monte Rosa Therapeutics(GLUE.US) With Buy Rating, Maintains Target Price $29
Market Newswire · 2026/6/24
Company notice
AEON Fantasy Co Ltd: It's exactly the same as real. The BIG buffer debut of liquid glue Yamato Aravik will be launched in the online ink game "MOLLY.ONLINE" on Friday, December 3.
JPX · 2021/12/2
Company notice
AEON Fantasy Co Ltd: Glue Specialty × MOLLY.ONLINE first Cooperative Commodity "Kouyama Yumu" and "Snow Whitening" Limited Cooperative Commodity will start at 18:00 on Monday, August 2nd.
JPX · 2021/8/2
Rating change
LifeSci Capital Maintains Monte Rosa Therapeutics(GLUE.US) With Buy Rating
Market Newswire · 2026/10/2

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-08 09:06:36 · For reference only, not investment advice and not tailored to your situation.